+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Assisted Reproductive Technology Market (ART) - Global Forecast 2026-2032- Product Image
Assisted Reproductive Technology Market (ART) - Global Forecast 2026-2032- Product Image
Sale

Assisted Reproductive Technology Market (ART) - Global Forecast 2026-2032

  • Report

  • 187 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904634
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Assisted Reproductive Technology Market is projected to reach USD 40.94 Billion in 2026. It is expected to continue growing at a CAGR of 18.11%, reaching USD 111.51 Billion by 2032.

Assisted reproductive technology is moving from a specialized infertility intervention to a core component of reproductive health care. The industry is anchored by in vitro fertilization, intracytoplasmic sperm injection, preimplantation genetic testing, cryopreservation, donor services, and fertility preservation for oncology-related and elective indications.

Demand is supported by verified demographic and clinical trends. The World Health Organization estimates that about one in six adults experience infertility during their lifetime, while national registries such as the CDC and SART in the United States show that ART accounts for more than 2% of U.S. births. Delayed parenthood, rising infertility diagnosis, improved embryo culture systems, and broader insurance or employer-sponsored fertility benefits are reshaping access, patient expectations, and competitive positioning.

Transformative Shifts in the ART Landscape

The assisted reproductive technology landscape is being transformed by patient-centric care models, laboratory digitization, and expanding fertility preservation. Clinics are increasingly combining IVF, ICSI, PGT, vitrification, genetic counseling, and telehealth-enabled patient engagement to improve treatment continuity, transparency, and clinical coordination.

Regulation is also reshaping market behavior. Data privacy rules, embryo handling standards, donor screening requirements, tissue and cell traceability, and advertising controls are becoming more important as cross-border fertility care expands. Providers that can document live birth outcomes, laboratory quality, ethical governance, and equitable access are better positioned to gain patient, clinician, and payer confidence.

Cumulative Impact of Artificial Intelligence in ART

Artificial intelligence is beginning to influence ART through embryo image assessment, sperm selection support, workflow automation, ovarian stimulation decision support, and predictive analytics for cycle management. These tools are most valuable when they reduce variability, enhance documentation, support laboratory consistency, and help embryologists prioritize embryos using standardized, auditable data.

The cumulative impact of AI will depend on clinical validation rather than marketing claims. Regulators, clinicians, and patients increasingly expect evidence that AI systems improve decision-making without introducing bias, privacy risk, or unproven outcome promises. Industry leaders should treat AI as a quality-enhancing layer integrated with embryologist expertise, not as a replacement for clinical judgment.

Key Regional Insights for ART Markets

Asia-Pacific is a dynamic ART region due to large reproductive-age populations, rising infertility awareness, medical travel, and expanding clinic networks in India, China, Japan, South Korea, Thailand, Singapore, and Australia. China and India offer scale through urbanization and growing private fertility care, while Japan and South Korea are shaped by low fertility rates and government attention to family formation. Australia remains a well-regulated market with advanced fertility services and registry-supported clinical standards.

North America is characterized by advanced clinical infrastructure, CDC and SART reporting standards, employer fertility benefits, and strong uptake of PGT, egg freezing, and donor services. Latin America is led by Brazil and Mexico, where private clinics and cross-border affordability attract domestic and international patients. Europe remains one of the most regulated ART environments, supported by ESHRE-linked registry activity, national reimbursement differences, mature fertility clinic networks, and strict frameworks for gamete donation, embryo transfer, and patient consent.

The Middle East is gaining momentum through the UAE, Saudi Arabia, and Qatar, where private health investment and family-building priorities support premium IVF services within culturally specific regulatory frameworks. Africa remains underpenetrated, but Egypt, South Africa, Nigeria, and Kenya are expanding ART access as urban fertility centers, specialist training, reproductive health awareness, and private investment improve availability.

Key Group Insights Across Global ART Demand

ASEAN is emerging as an important fertility care corridor, with Thailand, Malaysia, Singapore, Vietnam, Indonesia, and the Philippines showing different levels of clinic maturity, affordability, and regulatory oversight. Singapore emphasizes high-quality specialty care and strict medical standards, while Thailand and Malaysia benefit from regional medical travel, competitive private fertility services, and growing patient awareness.

The GCC is shaped by high private health expenditure, expanding specialty hospitals, and strong demand for culturally compliant fertility services. The European Union emphasizes safety, traceability, data protection, and quality systems, making compliance with tissue, cell, medical device, and privacy rules central to ART operations. BRICS countries collectively represent major procedure-volume potential, particularly through China, India, and Brazil, where large populations, delayed parenthood, urban health care access, and expanding private care ecosystems support long-term ART adoption.

G7 markets lead in technology adoption, clinical research, advanced genetic testing, fertility preservation, and registry-based reporting, though reimbursement and patient access vary widely. NATO countries are not a fertility-specific bloc, but many member states overlap with advanced North American and European ART markets where supply chain resilience, cybersecurity, health data governance, and continuity of cryostorage operations increasingly influence clinical decision-making.

Key Country Insights Shaping ART Adoption

The United States leads in ART innovation, private clinic consolidation, employer benefits, and adoption of PGT and egg freezing, with CDC reporting that ART contributes more than 2% of national births. Canada combines public funding in selected provinces with private clinic growth, while Mexico attracts cross-border patients seeking affordability and flexible treatment access. Brazil is Latin America’s largest ART center of activity, supported by specialist clinics, medical societies, and rising fertility awareness.

In Europe, the United Kingdom is guided by HFEA oversight and transparent clinic reporting, Germany and France operate within structured reimbursement and regulatory systems, Italy and Spain remain important IVF destinations, and Spain is especially recognized for donor egg treatment under established reproductive medicine regulation. Russia has historically been a sizable ART market, although geopolitical, payment, and international travel risks affect cross-border participation.

China and India represent high-volume opportunity due to population scale, urbanization, delayed marriage, infertility awareness, and expanding fertility clinic networks. Japan and South Korea face demographic urgency from low birth rates, supporting policy attention to fertility services, financial assistance, and fertility preservation. Australia has a mature ART ecosystem with strong clinical standards and registry participation, while South Korea combines advanced health technology with growing public concern over fertility decline.

Actionable Recommendations for ART Industry Leaders

Industry leaders should prioritize measurable outcomes, ethical transparency, and patient affordability. Clinics and technology providers can strengthen market position by publishing validated success metrics, improving cycle-level data quality, and supporting patients with financing, counseling, genetic education, and clear treatment pathways.

Strategic investment should focus on laboratory standardization, embryology workforce development, AI governance, cryostorage risk management, secure digital patient platforms, and compliance-ready documentation. Expansion plans should be tailored to local reimbursement, donor rules, embryo regulations, data protection requirements, and cultural expectations rather than relying on a uniform global model.

Research Methodology for ART Market Intelligence

This executive summary is based on triangulated secondary research from recognized public health agencies, fertility registries, clinical society publications, regulatory sources, demographic databases, and publicly available health system information. Key reference points include WHO infertility estimates, CDC and SART ART surveillance, ESHRE registry work, HFEA reporting, and national reproductive medicine guidelines.

The methodology evaluates demand drivers, procedure adoption, technology trends, reimbursement structures, regional regulations, competitive behavior, and patient access dynamics. Insights are validated through cross-comparison of registry data, peer-reviewed clinical evidence, regulatory signals, demographic indicators, and market activity to ensure fact-based interpretation without using market sizing, share, or forecasting assumptions.

Conclusion on the Future of Assisted Reproductive Technology

Assisted reproductive technology is set for sustained relevance as infertility prevalence, delayed parenthood, fertility preservation, and demographic pressures converge. The strongest opportunities will come from providers that combine clinical excellence with transparent outcomes, digital engagement, responsible AI, compliant cryostorage, and well-governed cross-border service models.

Future industry leadership will depend on trust. Organizations that align innovation with evidence, patient safety, ethical governance, regulatory compliance, and affordability will be best positioned to serve patients across mature and emerging ART markets.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Assisted Reproductive Technology Market, by Product
7.1. Introduction
7.2. Consumables
7.3. Equipment
7.4. Media And Reagents
8. Assisted Reproductive Technology Market, by Procedure Type
8.1. Introduction
8.2. Gamete Intrafallopian Transfer
8.3. In Vitro Fertilization
8.3.1. Fresh Donor
8.3.2. Fresh Non-Donor
8.3.3. Frozen
8.4. Intracytoplasmic Sperm Injection
8.5. Intrauterine Insemination
8.6. Zygote Intrafallopian Transfer
9. Assisted Reproductive Technology Market, by Cycle Type
9.1. Introduction
9.2. Fresh Donor
9.3. Fresh Non-Donor
9.4. Frozen
10. Assisted Reproductive Technology Market, by Infertility Type
10.1. Introduction
10.2. Female Infertility
10.2.1. Ovulation disorders
10.2.2. Tubal blockage
10.2.3. Endometriosis
10.3. Male Infertility
10.3.1. Low sperm count
10.3.2. Poor motility
10.3.3. Azoospermia
10.4. Unexplained Infertility
10.5. Age-related Infertility
11. Assisted Reproductive Technology Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Fertility Clinics
11.4. Hospitals
12. Assisted Reproductive Technology Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Assisted Reproductive Technology Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Assisted Reproductive Technology Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. BioIVT, LLC
16.2. BioLife Solutions, Inc.
16.3. Carl Zeiss AG
16.4. CIVCO Medical Solutions
16.5. Cook Medical LLC
16.6. CooperSurgical Inc
16.7. Corning Incorporated
16.8. CryoLogix LLC
16.9. Cryoport, Inc.
16.10. Eppendorf AG
16.11. Esco Lifesciences Group Ltd
16.12. Ferring Pharmaceuticals A/S
16.13. FUJIFILM Irvine Scientific Sales Company, Inc.
16.14. Genea Biomedx Pty Ltd
16.15. Hamilton Thorne Ltd.
16.16. Hunter Scientific Ltd.
16.17. IMV Technologies
16.18. IVF Express
16.19. IVFsynergy Ltd
16.20. Kitazato Corporation
16.21. Labotect GmbH
16.22. Memmert GmbH + Co. KG
16.23. Merck KGaA
16.24. Nidacon International AB
16.25. Olympus Corporation
16.26. Progyny, Inc.
16.27. The Cooper Companies, Inc.
16.28. Thermo Fisher Scientific Inc.
16.29. TMRW Life Sciences, Inc.
16.30. Vitrolife AB
List of Figures
FIGURE 1. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CONSUMABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CONSUMABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CONSUMABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL EQUIPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL MEDIA AND REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL MEDIA AND REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL MEDIA AND REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL GAMETE INTRAFALLOPIAN TRANSFER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL GAMETE INTRAFALLOPIAN TRANSFER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL GAMETE INTRAFALLOPIAN TRANSFER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL IN VITRO FERTILIZATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL IN VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL IN VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL FRESH DONOR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL FRESH DONOR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL FRESH DONOR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL FRESH NON-DONOR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL FRESH NON-DONOR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL FRESH NON-DONOR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL FROZEN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL FROZEN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL FROZEN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL INTRACYTOPLASMIC SPERM INJECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL INTRACYTOPLASMIC SPERM INJECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL INTRACYTOPLASMIC SPERM INJECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL INTRAUTERINE INSEMINATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL INTRAUTERINE INSEMINATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL INTRAUTERINE INSEMINATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL ZYGOTE INTRAFALLOPIAN TRANSFER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL ZYGOTE INTRAFALLOPIAN TRANSFER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL ZYGOTE INTRAFALLOPIAN TRANSFER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL FRESH DONOR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL FRESH DONOR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL FRESH DONOR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL FRESH NON-DONOR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL FRESH NON-DONOR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL FRESH NON-DONOR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL FROZEN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL FROZEN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL FROZEN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL FEMALE INFERTILITY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL FEMALE INFERTILITY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL FEMALE INFERTILITY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL OVULATION DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL OVULATION DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL OVULATION DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL TUBAL BLOCKAGE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL TUBAL BLOCKAGE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL TUBAL BLOCKAGE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL ENDOMETRIOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL ENDOMETRIOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL ENDOMETRIOSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL MALE INFERTILITY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL MALE INFERTILITY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL MALE INFERTILITY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL LOW SPERM COUNT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL LOW SPERM COUNT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL LOW SPERM COUNT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL POOR MOTILITY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL POOR MOTILITY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL POOR MOTILITY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL AZOOSPERMIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL AZOOSPERMIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL AZOOSPERMIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL UNEXPLAINED INFERTILITY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL UNEXPLAINED INFERTILITY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL UNEXPLAINED INFERTILITY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL AGE-RELATED INFERTILITY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL AGE-RELATED INFERTILITY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL AGE-RELATED INFERTILITY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL FERTILITY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL FERTILITY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL FERTILITY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2017-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2017-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2017-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 97. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 98. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 99. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 101. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 102. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2017-2032 (USD MILLION)
TABLE 103. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2017-2032 (USD MILLION)
TABLE 104. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2017-2032 (USD MILLION)
TABLE 105. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 106. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 107. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 108. LATIN AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. LATIN AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 110. LATIN AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 111. LATIN AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2017-2032 (USD MILLION)
TABLE 112. LATIN AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2017-2032 (USD MILLION)
TABLE 113. LATIN AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2017-2032 (USD MILLION)
TABLE 114. LATIN AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 115. LATIN AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 116. LATIN AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 117. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 119. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 120. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2017-2032 (USD MILLION)
TABLE 121. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2017-2032 (USD MILLION)
TABLE 122. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2017-2032 (USD MILLION)
TABLE 123. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 124. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 125. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 126. MIDDLE EAST ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. MIDDLE EAST ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 128. MIDDLE EAST ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 129. MIDDLE EAST ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2017-2032 (USD MILLION)
TABLE 130. MIDDLE EAST ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2017-2032 (USD MILLION)
TABLE 131. MIDDLE EAST ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2017-2032 (USD MILLION)
TABLE 132. MIDDLE EAST ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 133. MIDDLE EAST ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 134. MIDDLE EAST ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 135. AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 136. AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 137. AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 138. AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2017-2032 (USD MILLION)
TABLE 139. AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2017-2032 (USD MILLION)
TABLE 140. AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2017-2032 (USD MILLION)
TABLE 141. AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 142. AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 143. AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 145. ASEAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 146. ASEAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 147. ASEAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 148. ASEAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2017-2032 (USD MILLION)
TABLE 149. ASEAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2017-2032 (USD MILLION)
TABLE 150. ASEAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2017-2032 (USD MILLION)
TABLE 151. ASEAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 152. ASEAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 153. ASEAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 154. GCC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 155. GCC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 156. GCC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 157. GCC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2017-2032 (USD MILLION)
TABLE 158. GCC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2017-2032 (USD MILLION)
TABLE 159. GCC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2017-2032 (USD MILLION)
TABLE 160. GCC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 161. GCC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 162. GCC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 163. EUROPEAN UNION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 164. EUROPEAN UNION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 165. EUROPEAN UNION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 166. EUROPEAN UNION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2017-2032 (USD MILLION)
TABLE 167. EUROPEAN UNION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2017-2032 (USD MILLION)
TABLE 168. EUROPEAN UNION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2017-2032 (USD MILLION)
TABLE 169. EUROPEAN UNION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 170. EUROPEAN UNION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 171. EUROPEAN UNION ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 172. BRICS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 173. BRICS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 174. BRICS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 175. BRICS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2017-2032 (USD MILLION)
TABLE 176. BRICS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2017-2032 (USD MILLION)
TABLE 177. BRICS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2017-2032 (USD MILLION)
TABLE 178. BRICS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 179. BRICS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 180. BRICS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 181. G7 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 182. G7 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 183. G7 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 184. G7 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2017-2032 (USD MILLION)
TABLE 185. G7 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2017-2032 (USD MILLION)
TABLE 186. G7 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2017-2032 (USD MILLION)
TABLE 187. G7 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 188. G7 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 189. G7 ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 190. NATO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 191. NATO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 192. NATO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 193. NATO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2017-2032 (USD MILLION)
TABLE 194. NATO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2017-2032 (USD MILLION)
TABLE 195. NATO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2017-2032 (USD MILLION)
TABLE 196. NATO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 197. NATO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 198. NATO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 199. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 200. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 201. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 202. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 203. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2017-2032 (USD MILLION)
TABLE 204. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2017-2032 (USD MILLION)
TABLE 205. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2017-2032 (USD MILLION)
TABLE 206. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 207. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 208. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 209. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 210. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 211. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 212. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2017-2032 (USD MILLION)
TABLE 213. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2017-2032 (USD MILLION)
TABLE 214. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2017-2032 (USD MILLION)
TABLE 215. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 216. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 217. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 218. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 219. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 220. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 221. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2017-2032 (USD MILLION)
TABLE 222. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2017-2032 (USD MILLION)
TABLE 223. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2017-2032 (USD MILLION)
TABLE 224. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 225. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 226. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 227. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 228. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 229. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 230. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2017-2032 (USD MILLION)
TABLE 231. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2017-2032 (USD MILLION)
TABLE 232. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2017-2032 (USD MILLION)
TABLE 233. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 234. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 235. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 236. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 237. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 238. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 239. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2017-2032 (USD MILLION)
TABLE 240. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2017-2032 (USD MILLION)
TABLE 241. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2017-2032 (USD MILLION)
TABLE 242. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 243. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 244. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 245. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 246. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 247. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 248. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2017-2032 (USD MILLION)
TABLE 249. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2017-2032 (USD MILLION)
TABLE 250. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2017-2032 (USD MILLION)
TABLE 251. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 252. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 253. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 254. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 255. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 256. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 257. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2017-2032 (USD MILLION)
TABLE 258. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2017-2032 (USD MILLION)
TABLE 259. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2017-2032 (USD MILLION)
TABLE 260. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 261. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 262. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 263. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 264. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 265. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 266. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2017-2032 (USD MILLION)
TABLE 267. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2017-2032 (USD MILLION)
TABLE 268. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2017-2032 (USD MILLION)
TABLE 269. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 270. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 271. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 272. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 273. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 274. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 275. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2017-2032 (USD MILLION)
TABLE 276. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2017-2032 (USD MILLION)
TABLE 277. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2017-2032 (USD MILLION)
TABLE 278. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 279. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 280. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 281. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 282. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 283. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 284. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2017-2032 (USD MILLION)
TABLE 285. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2017-2032 (USD MILLION)
TABLE 286. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2017-2032 (USD MILLION)
TABLE 287. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 288. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 289. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 290. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 291. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 292. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 293. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2017-2032 (USD MILLION)
TABLE 294. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2017-2032 (USD MILLION)
TABLE 295. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2017-2032 (USD MILLION)
TABLE 296. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 297. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 298. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 299. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 300. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 301. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 302. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2017-2032 (USD MILLION)
TABLE 303. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2017-2032 (USD MILLION)
TABLE 304. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2017-2032 (USD MILLION)
TABLE 305. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 306. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 307. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 308. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 309. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 310. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 311. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2017-2032 (USD MILLION)
TABLE 312. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2017-2032 (USD MILLION)
TABLE 313. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2017-2032 (USD MILLION)
TABLE 314. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 315. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 316. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 317. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 318. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 319. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 320. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2017-2032 (USD MILLION)
TABLE 321. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2017-2032 (USD MILLION)
TABLE 322. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INFERTILITY TYPE, 2017-2032 (USD MILLION)
TABLE 323. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FEMALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 324. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MALE INFERTILITY, 2017-2032 (USD MILLION)
TABLE 325. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 326. SOUTH KOREA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 327. SOUTH KORE

Companies Mentioned

  • BioIVT, LLC
  • BioLife Solutions, Inc.
  • Carl Zeiss AG
  • CIVCO Medical Solutions
  • Cook Medical LLC
  • CooperSurgical Inc
  • Corning Incorporated
  • CryoLogix LLC
  • Cryoport, Inc.
  • Eppendorf AG
  • Esco Lifesciences Group Ltd
  • Ferring Pharmaceuticals A/S
  • FUJIFILM Irvine Scientific Sales Company, Inc.
  • Genea Biomedx Pty Ltd
  • Hamilton Thorne Ltd.
  • Hunter Scientific Ltd.
  • IMV Technologies
  • IVF Express
  • IVFsynergy Ltd
  • Kitazato Corporation
  • Labotect GmbH
  • Memmert GmbH + Co. KG
  • Merck KGaA
  • Nidacon International AB
  • Olympus Corporation
  • Progyny, Inc.
  • The Cooper Companies, Inc.
  • Thermo Fisher Scientific Inc.
  • TMRW Life Sciences, Inc.
  • Vitrolife AB

Table Information

Report AttributeDetails
No. of Pages187
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 40.94 Billion
Forecasted Market Value ( USD ) by 2032 $ 111.51 Billion
Compound Annual Growth Rate18.1%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Infertility Treatment Market - Global Forecast 2026-2032 - Product Image

Infertility Treatment Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
In-Vitro Fertilization Market - Global Forecast 2026-2032 - Product Image

In-Vitro Fertilization Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Assisted Reproductive Technology Market Size and Share - Growth Analysis Report and Forecast Trends (2026-2035) - Product Image

Assisted Reproductive Technology Market Size and Share - Growth Analysis Report and Forecast Trends (2026-2035)

  • Report
  • 400 Pages
  • Global
From
Assisted Reproductive Technology Market - Product Image

Assisted Reproductive Technology Market

  • Report
  • 92 Pages
  • Global
From
Infertility Drugs Market Size, Share, Trends and Forecast by Drug Class, Route of Administration, Distribution Channel, End User, and Region, 2026-2034 - Product Image

Infertility Drugs Market Size, Share, Trends and Forecast by Drug Class, Route of Administration, Distribution Channel, End User, and Region, 2026-2034

  • Report
  • 143 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.